Ivermectin Explained: The Science Behind the Controversy

<p>📢 Ask Dr. Bikman’s Digital Mind (multilingual):</p><p><a href="https://benbikman.com/ben-bikmans-digital-ai-mind" rel="noopener noreferrer" target="_blank">https://benbikman.com/ben-bikmans-digital-ai-mind</a></p><br /><p>📢 Dr. Bikman’s Community &amp; Coaching Site: <a href="https://insuliniq.com" rel="noopener noreferrer" target="_blank">https://insuliniq.com</a></p><br /><p>Topic:</p><p>Ivermectin is a Nobel Prize-winning drug with emerging evidence showing it influences mitochondria, inflammation, and metabolic signaling pathways such as AMPK and FXR. While most data is still preclinical, its consistent mechanisms and strong safety record make it a compelling candidate for further research in cancer and metabolic disease.</p><br /><p>Summary:</p><p>Ivermectin has become one of the most controversial drugs in recent years, but beneath the political noise lies a compelling scientific story. In this lecture, Dr. Ben Bikman examines ivermectin strictly through the lens of peer-reviewed research, highlighting its origins as a Nobel Prize-winning antiparasitic drug and exploring its expanding role in metabolism, mitochondrial function, inflammation, and cancer biology.</p><br /><p>A central theme of the lecture is ivermectin’s impact on mitochondria, particularly its ability to inhibit complex I of the electron transport chain. This disruption creates an energy crisis within cells, activates AMPK, suppresses mTOR signaling, and can ultimately trigger apoptosis in cancer cells. Notably, these effects appear to be selective, with cancer cells showing greater sensitivity than healthy cells. Additional mechanisms—including inhibition of PAK1 and synergy with existing chemotherapy agents—further support ivermectin’s potential as a therapeutic candidate in oncology.</p><br /><p>Beyond cancer, ivermectin demonstrates meaningful metabolic effects. It reduces inflammation through suppression of NF-kappaB, activates AMPK, and influences glucose metabolism via FXR signaling. Preclinical studies show improvements in insulin sensitivity, glucose control, liver health, and even adipocyte behavior. While human data is still limited, Dr. Bikman emphasizes that the mechanistic consistency across pathways warrants serious clinical investigation rather than dismissal.</p><br /><p>References:</p><p>For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&amp;A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: <a href="https://www.benbikman.com" rel="noopener noreferrer" target="_blank">https://www.benbikman.com</a></p><br /><p>NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.</p><br /><p>Ben’s favorite yerba mate and fiber: <a href="https://ufeelgreat.com/usa/en/c/1BA884" rel="noopener noreferrer" target="_blank">https://ufeelgreat.com/usa/en/c/1BA884</a></p><br /><p>Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: <a href="https://cleanformnutrition.com/products/go-bhb" rel="noopener noreferrer" target="_blank">https://cleanformnutrition.com/products/go-bhb</a></p><br /><p>Ben’s favorite meal-replacement shake: <a href="https://gethlth.com" rel="noopener noreferrer" target="_blank">https://gethlth.com</a> (discount: BEN10)</p><hr /><p style="color: grey; font-size: 0.75em;"> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color: grey;" target="_blank">acast.com/privacy</a> for more information.</p>